Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics Inc. (IMDX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IMDX · as of Jun 8, 2026
Key Statistics
Explore Insight Molecular Diagnostics Inc. Data
imdx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 63.6%
The IMDX analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $12.00, representing +99.22% upside from the current price of $6.02.
Competitors & Peers
imdx competitorsIMDX
ARMP
CCCC
CDXS
CYBN
IVVDStock Performance
Full HistoryAbout Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics Inc. OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationa…
what is insight molecular diagnostics inc. · imdx stock overview · insight molecular diagnostics inc. company profile · who is insight molecular diagnostics inc. ceo · imdx NASDAQ · insight molecular diagnostics inc. headquarters · insight molecular diagnostics inc. business segments
About Stock Overview & Key Data
Insight Molecular Diagnostics Inc. (IMDX) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Dec 30, 2015. As of the latest trading session, IMDX stock price is $6.02, with a market capitalization of $156.2M. The stock has returned +109.35% over the past 12 months and -22.40% year-to-date.
According to 11 Wall Street analysts, the consensus rating for Insight Molecular Diagnostics Inc. stock is Buy, with an average 12-month price target of $12.00. In fiscal year 2025, Insight Molecular Diagnostics Inc. reported revenue of $4.1M and net income of -$50.2M. For detailed data — including Insight Molecular Diagnostics Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Insight Molecular Diagnostics Inc. (IMDX) stock price is $6.02. The stock is traded on NASDAQ under the ticker symbol IMDX. The 52-week range is $2.33 – $8.51.